Apexigen, Inc. Diluted Shares Outstanding (Weighted Average)
Apexigen, Inc. reported Diluted Shares Outstanding (Weighted Average) of 24.73 million shares for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2023-08-10
- Apexigen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2023-06-30 was 24.73M shares, a 36.68% increase year-over-year.
- Apexigen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2023-03-31 was 24.16M shares, a 33.58% increase year-over-year.
- Apexigen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-12-31 was 22.46M shares, a 24.44% increase year-over-year.
- Apexigen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-09-30 was 20.48M shares, a 13.54% increase year-over-year.
- Apexigen, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 19.79M shares, a 9.72% increase from fiscal 2021.
- Apexigen, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 18.03M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2023-06-30 | 24.73M shares 10-Q · filed 2023-08-10 | 24.44M shares 10-Q · filed 2023-08-10 | 23.78M shares derived: average of 3 quarters · filed 2023-08-10 | 22.96M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 24.16M shares 10-Q · filed 2023-05-15 | 23.31M shares derived: average of 2 quarters · filed 2023-05-15 | 22.37M shares derived: average of 3 quarters · filed 2023-05-15 | 21.30M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | 22.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | 21.47M shares derived: average of 2 quarters · filed 2023-02-22 | 20.35M shares derived: average of 3 quarters · filed 2023-08-10 | 19.79M shares 10-K · filed 2023-02-22 |
| 2022-09-30 | 20.48M shares 10-Q · filed 2022-11-14 | 19.29M shares derived: average of 2 quarters · filed 2023-08-10 | 18.90M shares 10-Q · filed 2022-11-14 | 18.68M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | 18.09M shares 10-Q · filed 2023-08-10 | 18.09M shares 10-Q · filed 2023-08-10 | 18.08M shares derived: average of 3 quarters · filed 2023-08-10 | 18.07M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 18.08M shares 10-Q · filed 2023-05-15 | 18.07M shares derived: average of 2 quarters · filed 2023-05-15 | 18.06M shares derived: average of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | 18.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | 18.05M shares derived: average of 2 quarters · filed 2023-02-22 | 18.03M shares 10-K · filed 2023-02-22 | |
| 2021-09-30 | 18.04M shares 10-Q · filed 2022-11-14 | 18.03M shares 10-Q · filed 2022-11-14 |